REN: Renin
Renin is a highly specific endopeptidase, whose only known function is to generate angiotensin I from angiotensinogen in the plasma, initiating a cascade of reactions that produce an elevation of blood pressure and increased sodium retention by the kidney. .
- Drugs that act on it: 3
- Approved: 1
- In phases 1 to 3: 2
- Sponsors: 2
Who is on it, and how far along
Every drug ChEMBL records acting on REN, by the furthest stage it has reached for any use, coloured by modality.
How to read this
Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
- Small molecule 3
| AliskirenBoxed warning | Approved | Novartis Pharmaceuticals | Small molecule | Inhibitor | 1 |
| Sitokiren | Phase 3 | Shanghai Pharmaceuticals Holding Co., Ltd | Small molecule | Inhibitor | 0 |
| Imarikiren | Phase 2 | — | Small molecule | Inhibitor | 0 |
| Trial | Drug | Phase | Status | Lead sponsor | First posted |
|---|---|---|---|---|---|
| Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy | Aliskiren | Phase 2 | Recruiting | Region Skane | Dec 3, 2019 |
- Familial juvenile hyperuricemic nephropathy type 20.76
- Renal tubular dysgenesis0.74
- Renal tubular dysgenesis of genetic origin0.73
- Hypertensive disorder0.67
- Stroke disorder0.47
- Essential hypertension0.43
- Hereditary disease0.42
- Cardiovascular disorder0.39
- Congenital anomaly of kidney and urinary tract0.37
- Diabetes mellitus0.35
- Heart failure0.34
- Atherosclerosis0.32
Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL286, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-22. Gene name, function (UniProt P00797, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets